Search - tctmd.com

Displaying 281 - 300 of 309

Sort: Relevancy | Date

Presentation TCT 2013

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Presenter: C. Michael Gibson

October 29, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

October 04, 2013

Presentation

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

Presenter: Ziad Hijazi

October 02, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

Yael L. Maxwell

August 09, 2013

Presentation

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Presenter: David Garcia

August 05, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

News Daily News

Meta-Analysis: Endovascular Therapy Suitable for Intracranial Aneurysms in Selected Elderly

Leah Lawrence

July 05, 2013

News Daily News

Meta Análisis: La Terapia Endovascular es Apta en el Tratamiento de Aneurismas Intracraneales en Ancianos Seleccionados

Leah Lawrence

July 05, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Yael L. Maxwell

May 03, 2013

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Presenter: Francisco Moniche

July 06, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

Advertisement

Acute Coronary Syndrome and Atrial Fibrillation: 1 + 1 = 5

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Meta-Analysis: Endovascular Therapy Suitable for Intracranial Aneurysms in Selected Elderly

Meta Análisis: La Terapia Endovascular es Apta en el Tratamiento de Aneurismas Intracraneales en Ancianos Seleccionados

Stroke After STEMI Unusual But Carries Poor Prognosis

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Intra-arterial Bone Marrow Mononuclear Cells in Ischemic Stroke

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content